| 股票代码 | 002030 | 当期评分 | ||||
| 股票名称 | 达安基因 | |||||
| 报告日期 | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-09-30 | 2020-09-30 |
| 每股经营现金流(¥) | -0.526 | -0.3034 | 0.4921 | 0.1166 | 1.2917 | ✔ |
| 销售净利润率(%) | 8.4493 | 6.2407 | 5.8659 | -4.3254 | 42.1926 | ✔ |
| 销售毛利率(%) | 43.0868 | 42.6988 | 41.0744 | 49.2194 | 68.5818 | ✔ |
| 净资产收益率(%) | 6.63 | 5.15 | 5.59 | 5.01 | 45.75 | ✔ |
| 营业增长率(%) | 9.1035 | -4.2488 | -4.2463 | -26.0726 | 366.2535 | ✔ |
| 净利润增长率(%) | 15.4221 | -29.2776 | -9.9974 | -154.5123 | 2099.1178 | ✔ |
| 每股收益(%) | 0.15 | 0.12 | 0.13 | 0.1156 | 1.7525 | ✔ |
| 现金流量比率(%) | -28.7389 | -13.8351 | 28.4418 | 8.3328 | 68.2474 | ✔ |
| 三项费用比重(%) | 36.4956 | 37.7676 | 30.1269 | 30.584 | 15.8372 | ✔ |
| 每股净资产(¥) | 2.2201 | 2.3176 | 2.2771 | 2.3094 | 3.8306 | ✔ |
| 流动比率(%) | 2.3085 | 2.0163 | 1.5328 | 1.5698 | 2.1083 | ✔ |
| 速动比率(%) | 2.1444 | 1.8884 | 1.4158 | 1.404 | 1.9332 | ✔ |
| 现金比率(%) | 110.7381 | 83.3909 | 31.7587 | 31.2605 | 31.2605 | ✔ |
| 总资产利润率(%) | 3.7851 | 2.1892 | 2.0833 | -1.3055 | 33.1535 | ✔ |
| 主营利润比重% | 455.9442 | 587.4771 | 594.9092 | 8869.3604 | 137.8445 | ✔ |
| 应收账款(万元) | 83,743.20 | 94,418.48 | 68,765.53 | 71,086.84 | 161,070.85 | ✔ |
| 应收票据(万元) | 98.47 | 673.98 | 2,298.00 | 344.14 | 230.76 | ✔ |
| 预付款项(万元) | 9,083.34 | 5,695.25 | 3,223.55 | 2,721.99 | 23,865.57 | ✔ |
| 存货(万元) | 21,777.33 | 20,322.79 | 16,130.93 | 18,499.68 | 29,062.61 | ✘ |
| 在建工程(万元) | -- | 14,582.66 | 92.29 | 557.76 | 988.91 | ✘ |
| 应付款项(万元) | 18,098.26 | 20,504.17 | 10,923.46 | 12,851.98 | 55,743.81 | ✘ |
| 长期借款(万元) | 20,000.00 | 32,480.00 | 4,970.00 | 29,000.00 | 17,900.00 | ✔ |
| 未分配利润(万元) | 17,468.27 | 22,069.10 | 22,257.75 | 24,122.60 | 167,940.57 | ✘ |
| 商誉(万元) | 600.68 | 600.68 | 600.68 | 600.68 | 626.48 | ✔ |
| 流动资产(万元) | 107,693.02 | 143,659.06 | 154,876.23 | 181,007.42 | 199,861.32 | ✔ |
| 流动负债(万元) | 132,670.49 | 158,968.13 | 137,958.35 | 111,574.80 | 166,021.92 | ✔ |
达安基因002030评分结果 | 81.82分 | 买入/增持 | ||||